Syngene International Ltd.

Syngene International Ltd is a premier integrated Contract Research, Development, and Manufacturing Organization (CRDMO) based in Bengaluru, 60. Established in 1993, Syngene provides comprehensive scientific solutions across the entire lifecycle of drug development—from discovery through to commercial production. Global Presence and Facilities Syngene operates a state-of-the-art 90-acre campus in Bengaluru, serving as the central hub for research, development, and manufacturing. Additional facilities include: Mangaluru: Specializes in commercial-scale Active Pharmaceutical Ingredient (API) manufacturing. Hyderabad: Hosts a discovery research hub. Baltimore, USA: Recently acquired biologics manufacturing facility, enhancing global capabilities. 🔬 Scientific Expertise and Services Syngene offers a broad spectrum of services through four key business divisions: Discovery Services: Provides early-stage research, including target identification and drug candidate delivery. Dedicated R&D Centers: Operates client-specific research facilities for large-scale projects. Development Services: Focuses on pre-clinical to clinical trials, including drug substance and product development. Manufacturing Services: Offers commercial-scale manufacturing for both small and large molecules. 🌍 Clientele and Collaborations Syngene collaborates with over 400 clients worldwide, ranging from large and mid-sized biopharma to emerging biotech firms. Notable partnerships include Bristol Myers Squibb, Amgen, and Baxter. 🌱 Commitment to Sustainability Syngene is dedicated to sustainability, with initiatives focusing on reducing carbon footprint, ensuring workplace safety, and positively impacting communities. The company sources 92% of its power from renewable energy and recycles 95% of its waste. For more information, visit Syngene International Ltd .